Why Large Health Systems Struggle With Lab and Pathology Billing

Laboratory and pathology billing rarely stays simple as health systems expand.

Growth often brings multiple performing labs, facilities, payer contracts, and billing workflows that were not originally designed to operate together. It can also create additional layers between operational, clinical, and reimbursement teams, making coordination more difficult.

The challenge is not a lack of scale—it is a lack of alignment.

When lab and pathology billing becomes absorbed into broader enterprise revenue cycle operations, specialty-specific requirements can be harder to manage. Organizations may struggle to respond quickly to payer changes, maintain consistent billing practices across locations, or identify where reimbursement opportunities are being missed.

As complexity increases, the risk of revenue leakage and administrative burden grows alongside it. 

One of the biggest challenges is that pathology billing is fundamentally different from general hospital billing, with unique reimbursement requirements that many enterprise billing models were never built to address.

A single pathology case may involve multiple CPT codes, separate technical and professional components, and payer-specific documentation requirements. Molecular and specialty testing can add further layers of reimbursement scrutiny, while high-volume claim activity can make revenue leakage difficult to identify without specialized oversight.

As a result, billing processes designed for the broader health system do not always provide the visibility or expertise needed to support pathology reimbursement effectively. Claims may continue to move through the revenue cycle, but opportunities to maximize reimbursement, prevent denials, and identify lost revenue can be harder to detect.

Even when health systems have experienced internal teams, the reimbursement landscape continues to evolve.

Payer requirements change, coverage policies shift, and documentation standards become more demanding. Prior authorization requirements expand, reimbursement pressure increases, and new administrative burdens emerge. What worked a year ago may no longer be enough to support optimal reimbursement performance.

This creates a critical challenge for laboratory and pathology revenue cycle operations: how quickly can organizations adapt?

Health systems must be able to identify payer changes, translate them into operational workflows, and consistently apply them across billing processes. The longer that gap remains, the greater the risk of underpayments, denials, delayed reimbursement, and missed revenue opportunities.

This is often where friction begins to emerge. Laboratory and pathology teams may rely on broader enterprise resources for billing support, while specialty-specific reimbursement requirements continue to change. When operational workflows cannot keep pace, revenue leakage becomes more difficult to prevent.

Another challenge for large health systems is that enterprise revenue cycle models are designed to support a wide range of services, not the specialized reimbursement requirements of laboratory and pathology billing.

This distinction matters because the reimbursement profile for lab and pathology services looks very different from many other areas of the health system. While higher-dollar inpatient and outpatient claims often receive the most attention, laboratory and pathology revenue is driven by a large volume of lower-dollar claims.

As the chart below illustrates, the average allowed amount for hospital claims is significantly higher than it is for lab and pathology claims. As a result, reimbursement issues that may appear minor on an individual claim can create substantial financial impact when repeated across thousands of claims.

Missed payer requirements, coding inconsistencies, documentation gaps, and underpayments can accumulate quietly, making revenue leakage difficult to detect without dedicated oversight.

That is why pathology billing requires more than efficient claims processing. It requires specialty expertise, payer-specific workflows, and the visibility to identify reimbursement issues before they scale into larger revenue cycle challenges.

The challenge for many large health systems is not a lack of scale. It is a lack of visibility into the reimbursement and operational factors that drive pathology performance.

Laboratory and pathology billing requires specialized workflows, payer-specific expertise, and close coordination across clinical, operational, and revenue cycle teams. These requirements can be difficult to maintain when billing processes are managed within broader enterprise structures.

This is where the difference between activity and control becomes clear.

Claims may be moving through the revenue cycle. Payments may be posting. Denials may be actively managed. But without clear visibility into payer behavior, workflow performance, and reimbursement trends, it can be difficult to identify where revenue is being lost.

Missed payer updates, breakdowns in pathology-specific workflows, underpayments, and reimbursement reductions often occur gradually rather than all at once. Without the tools and oversight to surface those issues quickly, organizations may continue operating at scale while missing opportunities to improve financial performance.

Ultimately, scale delivers value only when it is paired with the visibility and control needed to turn operational activity into optimized reimbursement outcomes.

Laboratory and pathology billing are not simply extensions of broader hospital billing. They require specialized expertise, aligned workflows, and clear visibility into reimbursement performance.

That is why even large, well-resourced health systems continue to face revenue cycle challenges. The issue is rarely scale itself. It is whether the billing model is built to support the unique demands of laboratory and pathology reimbursement.

As payer requirements evolve and reimbursement pressure increases, health systems need more than efficient claims processing. They need the ability to identify risks, adapt quickly, and uncover opportunities to improve financial performance. 

If your organization is relying on a broad enterprise billing structure to support laboratory and pathology services, it may be time to evaluate whether your current approach is delivering the visibility, responsiveness, and specialty expertise needed to maximize reimbursement.